Stephens analyst Mason Carrico reiterated an Equal Weight rating and $30.00 price target on Myriad Genetics (NASDAQ: MYGN).The analyst comments ...

This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE